Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hybrigenics Makes Fee-for-service Activities To Fully Owned Subsidiary
Hybrigenics got approval for the launch of Hybrigenics Services SAS subsidiary on June 25, 2010. The company said that this business generated EUR 3.27m revenue in 2009 and
Hybrigenics got approval for the launch of Hybrigenics Services SAS subsidiary on June 25, 2010. The company said that this business generated EUR 3.27m revenue in 2009 and
MOR202 is a fully human, HuCAL antibody directed against CD38, a membrane- bound glycoprotein that is a potential therapeutic target for the treatment of multiple myeloma and certain
PSR claimed that OrphanIQ reduces the time spent by the companies involved in orphan drug development to ask a short question on a variety of topics by avoiding
According to the agreement, Swedish Orphan Biovitrum will be dealing with the marketing and sales of Dongbao’s pipeline of biopharmaceuticals and other drugs in Europe. Whereas, Dongbao will
Bafna said that Clonazepam, for oral administration, falls under a group of drugs called benzodiazepines. Clonazepam is used to control certain types of seizures in the treatment of
Peter Schulz-Knappe, CSO and executive vice president of diagnostics at Protagen, said: “Also classical infectious disease diagnostics can benefit from UNIarray, the proprietary technology platform of Protagen for
Erwinase is an L-asparaginase derived from Erwinia chrysanthemi, used for the treatment of acute lymphoblastic leukemia in combination with other anti-neoplastic agents. Erwinase is currently approved for use
Synexus’ new research centre is expected to have the capacity for four full-time investigators, with an increase from 100 to 300 square metres of space and is also
Novozymes Biopharma claimed that its sodium hyaluronate was awarded the CPhI Gold Innovation Award for its production process allowing for better safety and improved consistency. Following this sample
Girindus said that the oligonucleotide product is a single strand phosphorothioate compound which has been granted an orphan drug designation. Girindus stated that the process validation program to